CLBT

Cellebrite DI Ltd.

55
Fundamentals62/ 100
Valuation50/ 100
Upside potential61/ 100
Risk potential24/ 100

CLBT has lower modeled downside risk, despite its lower overall score.

INTC

Intel Corporation

65
Fundamentals73/ 100
Valuation50/ 100
Upside potential64/ 100
Risk potential42/ 100

INTC has the edge over CLBT overall, supported by stronger fundamentals and stronger modeled upside.

CLBT Fundamentals

MetricStatus
Healthy
Stable
Strong
Strong

CLBT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.

INTC Fundamentals

MetricStatus
Healthy
Under pressure
Healthy
Healthy

INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.

CLBT PE Valuation

CHEAPFAIREXPENSIVE33x65x98x131x
CHEAPFAIREXPENSIVE33x65x98x131x
LevelPEPriceVs current
Cheap7.1x$1.64-85%
Forward33x$10.89—
Fair44x$10.10-7.3%
Current47x$10.89—
Expensive62x$14.35+32%

Historical ranges are pointers, not guarantees.

CLBT's PE is in its fair range at 47x, but its recent earnings include one-off gains. If earnings grow as analysts expect, today's price would be 33x next year's earnings.

INTC PE Valuation

INTC has no meaningful PE right now: it lost money over the past year.

CLBT Forward outlook

MetricOutlook
Strongly improving
Growth
Growth
Weakening
Limited
Moderate

Analysts expect earnings and revenue growth for CLBT, but weaker profitability.

INTC Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Broad
Low

INTC has the edge over CLBT on the outlook, with more favorable profitability expectations.

CLBT Risk to reward

ScenarioChangePrice
Upside+38%$15.03
Downside-24%$8.25

Calculated from the latest close: $10.89 on Nov 12.

CLBT trails INTC on modeled risk to reward, with less potential upside relative to its potential downside.

INTC Risk to reward

ScenarioChangePrice
Upside+76%$107.41
Downside-42%$35.74

Calculated from the latest close: $61.20 on Nov 12.

INTC has a better modeled risk to reward balance than CLBT, with more potential upside relative to its potential downside.

CLBT Earnings Per Share

Q3 2023: $-0.32Q4 2023: $-0.43Q1 2024: $-0.57Q2 2024: $-0.52Q3 2024: $-1.55Q4 2024: $-1.39Q1 2025: $-0.96Q2 2025: $-0.76Q3 2025: $0.31Q4 2025: $0.31Q1 2026: $0.29Q2 2026: $0.23Forward: $0.33
Q3 2023: $-0.32Q4 2023: $-0.43Q1 2024: $-0.57Q2 2024: $-0.52Q3 2024: $-1.55Q4 2024: $-1.39Q1 2025: $-0.96Q2 2025: $-0.76Q3 2025: $0.31Q4 2025: $0.31Q1 2026: $0.29Q2 2026: $0.23Forward: $0.33
QuarterTTM EPSYoY
Forward$0.33+46%
Q2 2026$0.23+$0.99
Q1 2026$0.29+$1.25
Q4 2025$0.31+$1.70
Q3 2025$0.31+$1.86
Q2 2025-$0.76-$0.24
Q1 2025-$0.96-$0.39
Q4 2024-$1.39-$0.96
Q3 2024-$1.55-$1.23

CLBT has the edge over INTC on earnings quality, reporting a profit while its opponent remains loss making.

INTC Earnings Per Share

Q4 2023: $0.40Q1 2024: $0.97Q2 2024: $0.24Q3 2024: $-3.71Q4 2024: $-4.38Q1 2025: $-4.48Q2 2025: $-4.77Q3 2025: $0.01Q4 2025: $-0.06Q1 2026: $-0.60Q2 2026: $-2.09Q3 2026: $-2.39Forward: $1.41
Q4 2023: $0.40Q1 2024: $0.97Q2 2024: $0.24Q3 2024: $-3.71Q4 2024: $-4.38Q1 2025: $-4.48Q2 2025: $-4.77Q3 2025: $0.01Q4 2025: $-0.06Q1 2026: $-0.60Q2 2026: $-2.09Q3 2026: $-2.39Forward: $1.41
QuarterTTM EPSYoY
Forward$1.41—
Q3 2026-$2.39-24000%
Q2 2026-$2.09+$2.68
Q1 2026-$0.60+$3.88
Q4 2025-$0.06+$4.32
Q3 2025$0.01+$3.72
Q2 2025-$4.77-2088%
Q1 2025-$4.48-562%
Q4 2024-$4.38-1195%

INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.

CLBT Quarterly Revenue

Q3 2023: $84MQ4 2023: $93MQ1 2024: $90MQ2 2024: $96MQ3 2024: $107MQ4 2024: $109MQ1 2025: $108MQ2 2025: $113MQ3 2025: $126MQ4 2025: $129MQ1 2026: $128MQ2 2026: $131M
Q3 2023: $84MQ4 2023: $93MQ1 2024: $90MQ2 2024: $96MQ3 2024: $107MQ4 2024: $109MQ1 2025: $108MQ2 2025: $113MQ3 2025: $126MQ4 2025: $129MQ1 2026: $128MQ2 2026: $131M
QuarterRevenueYoY
Q2 2026$131.1M+16%
Q1 2026$128.3M+19%
Q4 2025$128.8M+18%
Q3 2025$126M+18%
Q2 2025$113.3M+18%
Q1 2025$107.5M+20%
Q4 2024$109M+17%
Q3 2024$106.9M+27%

CLBT has the edge over INTC on sales, with more consistent year-over-year improvement.

INTC Quarterly Revenue

Q4 2023: $15.4BQ1 2024: $12.7BQ2 2024: $12.8BQ3 2024: $13.3BQ4 2024: $14.3BQ1 2025: $12.7BQ2 2025: $12.9BQ3 2025: $13.7BQ4 2025: $13.7BQ1 2026: $13.6BQ2 2026: $16.1BQ3 2026: $16.5B
Q4 2023: $15.4BQ1 2024: $12.7BQ2 2024: $12.8BQ3 2024: $13.3BQ4 2024: $14.3BQ1 2025: $12.7BQ2 2025: $12.9BQ3 2025: $13.7BQ4 2025: $13.7BQ1 2026: $13.6BQ2 2026: $16.1BQ3 2026: $16.5B
QuarterRevenueYoY
Q3 2026$16.5B+21%
Q2 2026$16.1B+25%
Q1 2026$13.6B+7.2%
Q4 2025$13.7B-4.1%
Q3 2025$13.7B+2.8%
Q2 2025$12.9B+0.2%
Q1 2025$12.7B-0.4%
Q4 2024$14.3B-7.4%

INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.

CLBT Free Cash Flow

Q3 2023: $28MQ4 2023: $39MQ1 2024: $8MQ2 2024: $12MQ3 2024: $40MQ4 2024: $62MQ1 2025: $19MQ2 2025: $29MQ3 2025: $30MQ4 2025: $78MQ1 2026: $17MQ2 2026: $15M
Q3 2023: $28MQ4 2023: $39MQ1 2024: $8MQ2 2024: $12MQ3 2024: $40MQ4 2024: $62MQ1 2025: $19MQ2 2025: $29MQ3 2025: $30MQ4 2025: $78MQ1 2026: $17MQ2 2026: $15M
QuarterFree cash flowYoY
Q2 2026$14.5M-50%
Q1 2026$16.8M-9.1%
Q4 2025$78.3M+27%
Q3 2025$30M-25%
Q2 2025$29M+138%
Q1 2025$18.5M+134%
Q4 2024$61.7M+59%
Q3 2024$39.8M+42%

CLBT generated $140M in free cash flow over the past year, down 6.3% from the year before.

INTC Free Cash Flow

Q4 2023: −$2.1BQ1 2024: −$7.2BQ2 2024: −$3.4BQ3 2024: −$2.4BQ4 2024: −$2.7BQ1 2025: −$4.4BQ2 2025: −$1.5BQ3 2025: $121MQ4 2025: $800MQ1 2026: −$2.5BQ2 2026: $4.5BQ3 2026: $1.1B
Q4 2023: −$2.1BQ1 2024: −$7.2BQ2 2024: −$3.4BQ3 2024: −$2.4BQ4 2024: −$2.7BQ1 2025: −$4.4BQ2 2025: −$1.5BQ3 2025: $121MQ4 2025: $800MQ1 2026: −$2.5BQ2 2026: $4.5BQ3 2026: $1.1B
QuarterFree cash flowYoY
Q3 2026$1.1B+774%
Q2 2026$4.5B+$6B
Q1 2026-$2.5B+$1.8B
Q4 2025$800M+$3.5B
Q3 2025$121M+$2.5B
Q2 2025-$1.5B+$1.9B
Q1 2025-$4.4B+$2.8B
Q4 2024-$2.7B-$597M

INTC has the edge over CLBT on cash flow, with more consistent year-over-year improvement.

CLBT Total Shares

Q3 2023: 204MQ4 2023: 194MQ1 2024: 197MQ2 2024: 199MQ3 2024: 209MQ4 2024: 247MQ1 2025: 249MQ2 2025: 249MQ3 2025: 250MQ4 2025: 252MQ1 2026: 252MQ2 2026: 253M
Q3 2023: 204MQ4 2023: 194MQ1 2024: 197MQ2 2024: 199MQ3 2024: 209MQ4 2024: 247MQ1 2025: 249MQ2 2025: 249MQ3 2025: 250MQ4 2025: 252MQ1 2026: 252MQ2 2026: 253M
PeriodChange %Net change
Quarterly+0.3%+711K shares
1 year+1.5%+3.8M shares
3 years+34%+64.7M shares
5 years+35%+65.6M shares
Available history+35%+65.6M shares

CLBT has the edge over INTC on shareholder dilution, with a more favorable share count trend.

INTC Total Shares

Q4 2023: 4.2BQ1 2024: 4.2BQ2 2024: 4.3BQ3 2024: 4.3BQ4 2024: 4.3BQ1 2025: 4.3BQ2 2025: 4.4BQ3 2025: 4.5BQ4 2025: 4.5BQ1 2026: 5.1BQ2 2026: 5.1BQ3 2026: 5.3B
Q4 2023: 4.2BQ1 2024: 4.2BQ2 2024: 4.3BQ3 2024: 4.3BQ4 2024: 4.3BQ1 2025: 4.3BQ2 2025: 4.4BQ3 2025: 4.5BQ4 2025: 4.5BQ1 2026: 5.1BQ2 2026: 5.1BQ3 2026: 5.3B
PeriodChange %Net change
Quarterly+4%+203M shares
1 year+17%+776M shares
3 years+25%+1.1B shares
5 years+30%+1.2B shares
Available history+19%+834M shares

INTC has 5.3B diluted shares, up 17% from a year ago.

CLBT Net Leverage

Q3 2023: -0.8xQ4 2025: -0.8xQ1 2026: -0.9xQ2 2026: -1.0x
Q3 2023: -0.8xQ4 2025: -0.8xQ1 2026: -0.9xQ2 2026: -1.0x
QuarterNet LeverageStatus
Q2 2026-1.0xNet Cash
Q1 2026-0.9xNet Cash
Q4 2025-0.8xNet Cash
Q3 2023-0.8xNet Cash
Q2 2023-0.6xNet Cash
Q1 2023-0.4xNet Cash
Q4 2022-0.3xNet Cash
Q3 2022-0.4xNet Cash

CLBT has the edge over INTC on leverage, with a lower net debt burden relative to earnings.

INTC Net Leverage

Q4 2023: 4.4xQ1 2024: 4.4xQ2 2024: 4.3xQ3 2024: 23.8xQ1 2025: 69.6xQ3 2025: 4.0xQ4 2025: 3.4xQ1 2026: 3.9xQ2 2026: 3.1xQ3 2026: 2.0x
Q4 2023: 4.4xQ1 2024: 4.4xQ2 2024: 4.3xQ3 2024: 23.8xQ1 2025: 69.6xQ3 2025: 4.0xQ4 2025: 3.4xQ1 2026: 3.9xQ2 2026: 3.1xQ3 2026: 2.0x
QuarterNet LeverageStatus
Q3 20262.0xHealthy
Q2 20263.1xElevated
Q1 20263.9xElevated
Q4 20253.4xElevated
Q3 20254.0xElevated
Q1 202569.6xHigh
Q3 202423.8xHigh
Q2 20244.3xHigh

INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.

CLBT Weekly Momentum

MetricValueStatus
RSI41.7Neutral
Stochastic32.9Neutral

CLBT's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).

INTC Weekly Momentum

MetricValueStatus
RSI38.1Neutral
Stochastic7.7Oversold

INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).

CLBT PE vs Technology Sector

MetricCLBTSector medianRelative
PE47x28x67% above
PE %553916 pts above

CLBT is trading at 47x earnings, a 67% premium to the Technology sector's median of 28x, though its recent earnings include one-off gains.

INTC PE vs Technology Sector

MetricINTCSector medianRelative
PEN/A28x—

INTC has no meaningful PE right now: it lost money over the past year.

CLBT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$11.55.1% below
20 week MA$12.614% below
50 week MA$13.922% below
100 week MA$16.132% below
200 week MA$13.117% below

CLBT is in a downtrend: it's below all five of its weekly moving averages, and 17% below its 200-week average.

INTC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$88.431% below
20 week MA$95.336% below
50 week MA$79.323% below
100 week MA$52.118% above
200 week MA$42.544% above

INTC has the edge over CLBT on trend strength, trading above more of its moving averages.

CLBT Yearly ROI

YearStart priceEnd priceROI
2020$9.66$10.5+8.8%
2021$10.5$8.10-23%
2022$8.10$4.18-48%
2023$4.18$8.66+107%
2024$8.66$22.2+156%
2025$22.2$18.4-17%
2026 YTD$18.4$10.9-41%

CLBT's yearly returns have swung widely, from +156% in 2024 to −48% in 2022. It's down 41% so far in 2026.

INTC Yearly ROI

YearStart priceEnd priceROI
2020$60.1$47.1-22%
2021$47.1$51.3+9%
2022$51.3$26.1-49%
2023$26.1$50.3+93%
2024$50.3$20.3-60%
2025$20.3$36.2+78%
2026 YTD$36.2$61.2+69%

INTC has the edge over CLBT on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key